Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response-Reference-Cited by-同舟云学术

Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response

Published:2018-08 Issue:8 Volume:18 Page:533-540
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Mina Roberto,Petrucci Maria Teresa,Corradini Paolo,Spada Stefano,Patriarca Francesca,Cerrato Chiara,De Paoli Lorenzo,Pescosta Norbert,Ria Roberto^ORCID,Malfitano Alessandra,Musto Pellegrino,Baldini Luca,Guglielmelli Tommasina,Gamberi Barbara,Mannina Donato^ORCID,Benevolo Giulia,Zambello Renato,Falcone Antonietta Pia,Palumbo Antonio,Nagler Arnon,Calafiore Valeria,Hájek Roman,Spencer Andrew,Boccadoro Mario,Bringhen Sara

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference35 articles.

1. Multiple myeloma;Palumbo;N Engl J Med,2011

2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;N Engl J Med,1996

3. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

4. Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies;Moreau;J Clin Oncol,2011

5. Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma;Benson;Leuk Lymphoma,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Сравнительный анализ эффективности режимов мобилизации аутологичных гемопоэтических стволовых клеток у больных множественной миеломой;Clinical Oncohematology;2024-02-20

2. The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma;Translational Oncology;2022-08

3. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022;Bone Marrow Transplantation;2022-05-19

4. Evolution or revolution in multiple myeloma therapy and the role of the UK;British Journal of Haematology;2020-11

5. Advances in maintenance strategy in newly diagnosed multiple myeloma patients eligible for autologous transplantation;Expert Review of Hematology;2020-10-26